Nephrogenic Diabetes Insipidus
📧 Sign up to get email alerts when something new happens for Nephrogenic Diabetes Insipidus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration [Phase 2]
Phase 2 clinical trial evaluating probenecid for hereditary nephrogenic diabetes insipidus, with autosomal dominant polycystic kidney diseas…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus [Phase 2]
Phase 2 clinical trial investigating atorvastatin for lithium-induced nephrogenic diabetes insipidus has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Metformin and Congenital Nephrogenic Diabetes Insipidus [Phase 1]
Phase 1 trial of metformin for nephrogenic diabetes insipidus led by Emory University has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-02-12Clinical Trial Update: Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus [NA]
Clinical trial on pharmacologic treatment for nephrogenic diabetes insipidus has completed with results posted in 2018.